全文获取类型
收费全文 | 939篇 |
免费 | 67篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 13篇 |
妇产科学 | 16篇 |
基础医学 | 129篇 |
口腔科学 | 5篇 |
临床医学 | 109篇 |
内科学 | 259篇 |
皮肤病学 | 13篇 |
神经病学 | 72篇 |
特种医学 | 23篇 |
外科学 | 110篇 |
综合类 | 7篇 |
预防医学 | 65篇 |
眼科学 | 33篇 |
药学 | 52篇 |
中国医学 | 5篇 |
肿瘤学 | 92篇 |
出版年
2024年 | 3篇 |
2023年 | 19篇 |
2022年 | 36篇 |
2021年 | 80篇 |
2020年 | 28篇 |
2019年 | 65篇 |
2018年 | 71篇 |
2017年 | 33篇 |
2016年 | 36篇 |
2015年 | 31篇 |
2014年 | 49篇 |
2013年 | 58篇 |
2012年 | 118篇 |
2011年 | 74篇 |
2010年 | 35篇 |
2009年 | 20篇 |
2008年 | 38篇 |
2007年 | 35篇 |
2006年 | 32篇 |
2005年 | 25篇 |
2004年 | 21篇 |
2003年 | 8篇 |
2002年 | 16篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 3篇 |
1998年 | 3篇 |
1996年 | 3篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1989年 | 3篇 |
1987年 | 2篇 |
1979年 | 3篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1969年 | 5篇 |
1968年 | 3篇 |
1926年 | 1篇 |
1924年 | 1篇 |
1923年 | 2篇 |
1920年 | 1篇 |
1917年 | 1篇 |
1915年 | 1篇 |
1914年 | 3篇 |
1913年 | 2篇 |
1911年 | 1篇 |
1910年 | 1篇 |
排序方式: 共有1012条查询结果,搜索用时 15 毫秒
31.
32.
33.
Marine Azevedo Da Silva Archana Singh‐Manoux Martin J. Shipley Jussi Vahtera Eric J. Brunner Jane E. Ferrie Mika Kivimäki Hermann Nabi 《Journal of sleep research》2014,23(1):94-97
Depressive symptoms are associated with an increased risk of death, but most of this association remains unexplained. Our aim was to explore the contribution of sleep duration and disturbances to the association between depressive symptoms, all‐cause and cardiovascular disease mortality. A total of 5813 (4220 men and 1593 women) aged 50–74 years at baseline, participants of the British Whitehall II prospective cohort study, were included. Depressive symptoms, sleep duration and disturbances were assessed in 2003–04. Mortality was ascertained through linkage to the national mortality register until August 2012, with a mean follow‐up of 8.8 years. Depressive symptoms were associated with an increased risk of mortality from all causes [hazard ratio (HR) = 1.51; 95% confidence interval (CI): 1.16–1.97)] and cardiovascular diseases (HR = 1.63; 95% CI: 1.01–2.64) after adjustment for sociodemographic characteristics. Further adjustment for sleep duration and disturbances reduced the association between depressive symptoms and cardiovascular mortality by 21% (HR = 1.53; 95% CI: 0.91–2.57). Sleep seems to have a role, as a mediator or confounder, in explaining the association between depressive symptoms and cardiovascular mortality. These findings need replication in larger studies with longer follow‐up. 相似文献
34.
Farras JA Avouac J Meunier M Allanore Y 《Seminars in arthritis and rheumatism》2012,41(4):e1-2; author reply e2-3
35.
36.
37.
Sanchez O Planquette B Roux A Gosset-Woimant M Meyer G 《Seminars in respiratory and critical care medicine》2012,33(2):156-162
Risk stratification of patients with pulmonary embolism represents an important step and may help to guide initial therapeutic management. Pulmonary embolism can be stratified into several groups, with different risk of early death or complications based on the presence of several risk factors. High-risk pulmonary embolism is defined by shock or peripheral signs of hypoperfusion. It is a life-threatening emergency with high short-term mortality (>25%) requiring specific therapeutic strategy with inotropic agents and fibrinolysis. In normotensive patients with pulmonary embolism, the presence of right ventricular dysfunction assessed by echocardiography or myocardial injury based on elevated levels of biomarkers, is associated with an intermediate risk of early death. These patients require close monitoring, and the role of thrombolytic treatment is currently assessed in a large trial. Lastly, patients with normotensive pulmonary embolism and without right ventricular dysfunction or myocardial injury have a low risk of death and complications. These patients may be candidates for home treatment. Several scores combining these risk factors have been described. 相似文献
38.
39.
Marine Meunier Ramin Bazeli Antoine Feydy Jean-Luc Drape André Kahan Yannick Allanore 《Joint, bone, spine : revue du rhumatisme》2013,80(1):48-51
ObjectiveThe thymus plays a crucial role in immune system homeostasis. Thymic abnormalities have been reported in many autoimmune diseases, but data for systemic sclerosis (SSc) and rheumatoid arthritis (RA) are sparse. The aim of this study was to evaluate the prevalence and correlates of radiological incomplete involution of the thymus in SSc and RA patients, and in a non-autoimmune group of controls.MethodsAll patients were at least 40 years old: 96 SSc patients (median age 59 years, 80% women) and 65 RA patients (median age 57 years, 88% women) were compared with 32 control individuals (median age 63 years, 62% women). Pulmonary CT-scans performed for lung assessment were available for all individuals. For the purpose of our study, complete involution of the thymus was defined as the absence of a residual thymus or a gland thickness, corresponding to the short axis on the axial slice, of less than 7 mm. We defined incomplete involution of the thymus as a residual thymic tissue more than 7 mm thick.ResultsThe frequency of incomplete thymus involution was significantly higher in SSc and RA patients (respectively 15 and 14%) than in the control group (0%; P < 0.05). Incomplete thymus involution was associated with pulmonary restrictive syndrome in SSc patients, and with biotherapy and an absence of antinuclear antibodies in RA patients.ConclusionOur findings show that two autoimmune diseases, SSc and RA, are associated with incomplete thymus involution. 相似文献
40.
Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta‐analysis 下载免费PDF全文
Anne‐Hélène Querard Yohann Foucher Christophe Combescure Etienne Dantan David Larmet Marine Lorent Lise‐Marie Pouteau Magali Giral Florence Gillaizeau 《Transplant international》2016,29(4):403-415
In 2002, the United Network for Organ Sharing proposed increasing the pool of donor kidneys to include Expanded Criteria Donor (ECD). Outside the USA, the ECD definition remains the one used without questioning whether such a graft allocation criterion is valid worldwide. We performed a meta‐analysis to quantify the differences between ECD and Standard Criteria Donor (SCD) transplants. We paid particular attention to select studies in which the methodology was appropriate and we took into consideration the geographical area. Thirty‐two publications were included. Only five studies, all from the USA, reported confounder‐adjusted hazard ratios comparing the survival outcomes between ECD and SCD kidney transplant recipients. These five studies confirmed that ECD recipients seemed to have poorer prognosis. From 29 studies reporting appropriate survival curves, we estimated the 5‐year pooled nonadjusted survivals for ECD and SCD recipients. The relative differences between the two groups were lower in Europe than in North America, particularly for death‐censored graft failure. It is of primary importance to propose appropriate studies for external validation of the ECD criteria in non‐US kidney transplant recipients. 相似文献